Delivery Order SPE2DB22D1017-SPE2DB25FF9MG

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $36,954.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, and has an ultimate completion date of June 6, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,437.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price delivery order. The contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,566.46, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,467.52, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of October 17, 2024. The award was made on October 16, 2024 and does not have a set-aside designation, indicating open...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,703.45, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 6, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,012.53, is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,252.72, is for the delivery of JANUMET XR 50-1,000 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2023. The contract is not associated with a set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,744.17, is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,326.40, is for the delivery of JANUMET XR 50-1,000 MG tablets in quantities of 180 per bottle. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of December 14, 2023. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $4,047.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a type of pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of November 15, 2024. The contract is not designated as a set-aside and was awarded through open competition....
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF9MG
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,649.82, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/7/25, 1:16 PM